Source link : https://newshealth.biz/health-news/fda-approves-roflumilast-foam-for-scalp-body-psoriasis/
The foam formulation of the phosphodiesterase-4 (PDE4) inhibitor roflumilast has been approved by the US Food and Drug Administration (FDA) for treating plaque psoriasis of the scalp and body in adults and adolescents aged 12 years and older, according to an announcement from the manufacturer Arcutis Biotherapeutics. The 0.3% foam formulation of roflumilast (Zoryve) was […]
The post FDA Approves Roflumilast Foam for Scalp, Body Psoriasis first appeared on News Health.
—-
Author : News Health
Publish date : 2025-05-22 21:06:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8